Download PDF
Klin Monbl Augenheilkd 2017; 234(04): 543-545
DOI: 10.1055/s-0042-121573
Der interessante Fall
Georg Thieme Verlag KG Stuttgart · New York

Chloroquine Retinopathy under Inadequately Weight Adjusted Dosage: Early Detection by Multimodal Imaging

Chloroquin-Retinopathie unter inadäquater gewichtsorientierter Dosierung: Früherkennung durch multimodale Bildgebung
P. Arendt
1   Klinik Pallas, Olten, Switzerland (Director: Prof. Dr. Heinrich Gerding)
2   Department of Ophthalmology, Inselspital, Bern University Hospital, University of Bern, Switzerland (Director: Prof. Dr. Dr. Sebastian Wolf)
,
H. Gerding
1   Klinik Pallas, Olten, Switzerland (Director: Prof. Dr. Heinrich Gerding)
3   Department of Ophthalmology, University of Münster, Münster (Director: Prof. Dr. Nicole Eter)
› Author Affiliations
Further Information

Publication History

Publication Date:
06 March 2017 (online)

Also available at
    Permissions and Reprints

Introduction

Hydroxychloroquine and chloroquine are often used in the therapy of rheumatologic diseases. Retinopathy associated with this therapy is well described in literature. The reported incidence of retinopathy varies for both chloroquine (~ 10–20 %) and hydroxychloroquine (~ 1–4 %) [1], [2]. Presently relatively heterogenous recommendations exist for the intervals of ophthalmologic screenings as well as for the selection of examination techniques.

 

  • References

  • 1 Finbloom DS, Silver K, Newsome DA, Gunkel R. Comparison of hydroxychloroquine and chloroquine use and the development of retinal toxicity. J Rheumatol 1985; 12: 692-694
    PubMedGoogle Scholar
  • 2 Bernstein HN. Ophthalmologic considerations and testing in patients receiving long-term antimalarial therapy. Am J Med 1983; 75: 25-34
    CrossrefPubMedGoogle Scholar
  • 3 Chen E, Brown DM, Benz MS. et al. Spectral domain optical coherence tomography as an effective screening test for hydroxychloroquine retinopathy (the “flying saucer” sign). Clin Ophthalmol 2010; 4: 1151-1158
    PubMedGoogle Scholar
  • 4 Ascaso FJ, Rodríguez NA, San Miguel R. et al. The “flying saucer” sign on spectral domain optical coherence tomography in chloroquine retinopathy. Arthritis Rheum 2013; 65: 2322
    CrossrefPubMedGoogle Scholar
  • 5 Rüther K, Foerster J, Berndt S. et al. Variabilität der retinotoxischen Gesamtdosis Chloroquin/Hydroxychloroquin. Ophthalmologe 2007; 104: 875-880
    CrossrefPubMedGoogle Scholar
  • 6 Marmor MF, Kellner U, Melles RB. et al. Recommendations on screening for chloroquin and hydroxychloroquine retinopathy (2016 revison). Ophthalmology 2016; 123: 1386-1394
    CrossrefPubMedGoogle Scholar
  • 7 Araiza-Casillas R, Cárdenas F, Morales Y. et al. Factors associated with chloroquine-induced retinopathy in rheumatic diseases. Lupus 2004; 13: 119-124
    CrossrefPubMedGoogle Scholar
  • 8 Mavrikakis I, Sfikakis PP, Mavrikakis E. et al. The incidence of irreversible retinal toxicity in patients treated with hydroxychloroquine: A reappraisal. Ophthalmology 2003; 110: 1321-1326
    CrossrefPubMedGoogle Scholar
  • 9 Mackenzie AH. Dose refinements in long-term therapy of rheumatoid arthritis with antimalarials. Am J Med 1983; 75: 40-45
    PubMedGoogle Scholar